Somatostatin regulates tight junction function and composition in human keratinocytes

Experimental Dermatology

Volumn 19, Issue 10, 2010, Pages 888-894

  Vockel, Matthias ^a,b   Breitenbach, Ute ^b   Kreienkamp, Hans Jürgen ^a   Brandner, Johanna M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BEIERSDORF AG   (Germany)

Author keywords

Claudins; GPCR; Skin; SSTR; TER

Indexed keywords

CALCIUM; CARRIER PROTEIN; CLAUDIN; CYCLIC AMP; MESSENGER RNA; MPDZ PROTEIN, HUMAN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 3;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CYTOLOGY; FEMALE; GENETICS; HUMAN; KERATINOCYTE; MALE; METABOLISM; MIDDLE AGED; PERMEABILITY; TIGHT JUNCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIUM; CARRIER PROTEINS; CELLS, CULTURED; CLAUDINS; CYCLIC AMP; FEMALE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; PERMEABILITY; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; SOMATOSTATIN; TIGHT JUNCTIONS; YOUNG ADULT;

EID: 79952112171     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01101.x     Document Type: Article

References (34)

1. Patel Y C. Somatostatin and its receptor family. Front Neuroendocrinol 1999: 20: 157-198.
2. Hagströmer L, Emtestam L, Stridsberg M, Talme T. Expression pattern of somatostatin receptor subtypes 1-5 in human skin: an immunohistochemical study of healthy subjects and patients with psoriasis or atopic dermatitis. Exp Dermatol 2006: 15: 950-957.
3. Liew C W, Vockel M, Glassmeier G et al. Interaction of the human somatostatin receptor 3 with the multiple PDZ domain protein MUPP1 enables somatostatin to control permeability of epithelial tight junctions. FEBS Lett 2009: 583: 49-54.
4. Aijaz S, Balda M S, Matter K. Tight junctions: molecular architecture and function. Int Rev Cytol 2006: 248: 261-298.
5. Schneeberger E E, Lynch R D. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004: 286: C1213-C1228.
6. Brandner J M. Tight junctions and tight junction proteins in mammalian epidermis. Eur J Pharm Biopharm 2009: 72: 289-294.
7. Furuse M, Hata M, Furuse K et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002: 156: 1099-1111.
8. Tunggal J A, Helfrich I, Schmitz A et al. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J 2005: 24: 1146-1156.
9. Helfrich I, Schmitz A, Zigrino P et al. Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation. J Invest Dermatol 2007: 127: 782-791.
10. Yuki T, Haratake A, Koishikawa H, Morita K, Miyachi Y, Inoue S. Tight junction proteins in keratinocytes: localization and contribution to barrier function. Exp Dermatol 2007: 16: 324-330.
11. Elias P M, Ahn S K, Denda M et al. Modulations in epidermal calcium regulate the expression of differentiation-specific markers. J Invest Dermatol 2002: 119: 1128-1136.
12. Rheinwald J G, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975: 6: 331-343.
13. Ohnemus U, Kohrmeyer K, Houdek P et al. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Invest Dermatol 2008: 128: 906-916.
14. Brandner J M, Kief S, Grund C et al. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 2002: 81: 253-263.
15. Mancini A, Koch A, Stefan M, Niemann H, Tamura T. The direct association of the multiple PDZ domain containing proteins (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase activity. FEBS Lett 2000: 482: 54-58.
16. Gaudillere A, Misery L, Bernard C, Souchier C, Claudy A, Schmitt D. Presence of somatostatin in normal human epidermis. Br J Dermatol 1997: 137: 376-380.
17. Meyer T N, Hunt J, Schwesinger C, Denker B M. Galpha12 regulates epithelial cell junctions through Src tyrosine kinases. Am J Physiol Cell Physiol 2003: 285: C1281-C1293.
18. Donato R, Wood S A, Saunders I et al. Regulation of epithelial apical junctions and barrier function by Galpha13. Biochim Biophys Acta 2009: 1793: 1228-1235.
19. Lanaspa M A, Andres-Hernando A, Rivard C J, Dai Y, Berl T. Hypertonic stress increases claudin-4 expression and tight junction integrity in association with MUPP1 in IMCD3 cells. Proc Natl Acad Sci U S A 2008: 105: 15797-15802.
20. Van Itallie C, Rahner C, Anderson J M. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 2001: 107: 1319-1327.
21. Zimmerli S C, Kerl K, Hadj-Rabia S, Hohl D, Hauser C. Human epidermal Langerhans cells express the tight junction protein claudin-1 and are present in human genetic claudin-1 deficiency (NISCH syndrome). Exp Dermatol 2008: 17: 20-23.
22. Kirschner N, Poetzl C, Von Den Driesch P et al. Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines. Am J Pathol 2009: 175: 1095-1106.
23. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009: 206: 2937-2946.
24. Eispert A C, Fuchs F, Brandner J M, Houdek P, Wladykowski E, Moll I. Evidence for distinct populations of human Merkel cells. Histochem Cell Biol 2009: 132: 83-93.
25. Fantini F, Johansson O. Neurochemical markers in human cutaneous Merkel cells. An immunohistochemical investigation. Exp Dermatol 1995: 4: 365-371.
26. Pummi K, Malminen M, Aho H, Karvonen S L, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol 2001: 117: 1050-1058.
27. Peltonen S, Riehokainen J, Pummi K, Peltonen J. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Br J Dermatol 2007: 156: 466-472.
28. Talme T, Schultzberg M, Sundqvist K G, Marcusson J A. Colocalization of somatostatin- and HLA-DR-like immunoreactivity in dendritic cells of psoriatic skin. Acta Derm Venereol 1997: 77: 338-342.
29. Geisner B, Skavland J, Marcusson J A, Johansson O, Elsayed S. Psoriasis and somatostatin in serum. Acta Derm Venereol 2007: 87: 538-539.
30. Talme T, Schultzberg M, Sundqvist K G, Marcusson J A. Somatostatin- and factor XIIIa-immunoreactive cells in psoriasis during clobetasol propionate and calciprotriol treatment. Acta Derm Venereol 1999: 79: 44-48.
31. Venier A, De Simone C, Forni L et al. Treatment of severe psoriasis with somatostatin: four years of experience. Arch Dermatol Res 1988: 280: S51-S54.
32. Weber G, Klughardt G, Neidhardt M, Galle K, Frey H, Geiger A. Treatment of psoriasis with somatostatin. Arch Dermatol Res 1982: 272: 31-36.
33. Yoshida Y, Morita K, Mizoguchi A, Ide C, Miyachi Y. Altered expression of occludin and tight junction formation in psoriasis. Arch Dermatol Res 2001: 293: 239-244.
34. Watson R E, Poddar R, Walker J M et al. Altered claudin expression is a feature of chronic plaque psoriasis. J Pathol 2007: 212: 450-458.